Cookie Policy

Mereo BioPharma Group plc's website uses cookies. By continuing to browse you are agreeing to our use of cookies. Find out more about our Cookie Policy.

MREO: US$3.32 MPH: 56.50GBp
Mereo-Banner-Image.jpg

Working together to inspire, innovate and improve lives

See our latest news

News

17 Sep 2019 Interim Financial Results for the Six Months Ended June 30, 2019 and Corporate Update
17 Sep 2019 Mereo Biopharma 2019 Interim Results Conference Call
4 Sep 2019 Mereo announces phase 2b data at ASBMR Meeting
Press Releases

View our latest Corporate Presentation

section-img.jpg
17 SEP 2019 Corporate presentation
17 SEP 2019 Interim Financial Results for the Six Months Ended June 30, 2019 and Corporate Update Conference Call
profile-img.jpg
quote.svg

We continue to make strong progress in development of our product portfolio, in the hope of providing better treatment options for patients suffering from rare diseases

Denise Scots-Knight, CEO Our Mission